Seeking Alpha

More on Bacterin International (BONE): Q2 beats on a per share basis while coming in-line with...

More on Bacterin International (BONE): Q2 beats on a per share basis while coming in-line with revenue estimates. Total revenue grew by 9% Y/Y on higher wound care product sales, while fewer expenses and a jump in margins helped boost its bottom line. The company maintains its FY12 revenue guidance of $35M - $40M, in line, albeit at the lower end of Street estimates of $39.6M. Shares +7.8% AH.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector